321 related articles for article (PubMed ID: 33264481)
1. Liquid biopsy for esophageal cancer: Is detection of circulating cell-free DNA as a biomarker feasible?
Yuan Z; Wang X; Geng X; Li Y; Mu J; Tan F; Xue Q; Gao S; He J
Cancer Commun (Lond); 2021 Jan; 41(1):3-15. PubMed ID: 33264481
[TBL] [Abstract][Full Text] [Related]
2. Combining Solid and Liquid Biopsy for Therapy Monitoring in Esophageal Cancer.
Richter F; Henssen C; Steiert TA; Meissner T; Mehdorn AS; Röcken C; Franke A; Egberts JH; Becker T; Sebens S; Forster M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445849
[TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsy for Investigation of Cancer DNA in Esophageal Squamous Cell Carcinoma.
Smith RA; Lam AK
Methods Mol Biol; 2020; 2129():203-215. PubMed ID: 32056180
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy.
Kim EJ; Im HS; Lee J; Cho EH; Kim YH; Kim HR; Kim JH; Park SR
Curr Probl Cancer; 2021 Jun; 45(3):100685. PubMed ID: 33342577
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
Cervena K; Vodicka P; Vymetalkova V
Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and monitoring of virus-associated cancer using cell-free DNA.
Scholte LL; Bethony JM; Xian RR
Curr Opin Virol; 2023 Jun; 60():101331. PubMed ID: 37187125
[TBL] [Abstract][Full Text] [Related]
7. Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression.
Hoang AT; Vizio B; Chiusa L; Cimino A; Solerio D; Do NH; Pileci S; Camandona M; Bellone G
Int J Med Sci; 2021; 18(6):1406-1414. PubMed ID: 33628097
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell-free DNA 5-hydroxymethylcytosine and whole-genome sequencing signatures for early detection of esophageal cancer.
Lu D; Wu X; Wu W; Wu S; Li H; Zhang Y; Yan X; Zhai J; Dong X; Feng S; Zhang X; Sun F; Wang S; Cai K
Cell Death Dis; 2023 Dec; 14(12):843. PubMed ID: 38114477
[TBL] [Abstract][Full Text] [Related]
10. Advances in biomarker discovery using circulating cell-free DNA for early detection of hepatocellular carcinoma.
Liu M; Zhang Z; Zhang W; Liu SM
WIREs Mech Dis; 2023; 15(3):e1598. PubMed ID: 36697374
[TBL] [Abstract][Full Text] [Related]
11. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
Jiang P; Chan KCA; Lo YMD
J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
[TBL] [Abstract][Full Text] [Related]
12. Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study.
Qiao G; Zhuang W; Dong B; Li C; Xu J; Wang G; Xie L; Zhou Z; Tian D; Chen G; Tang J; Zhou H; Zhang D; Shi R; Chen R; Nian W; Zhang Y; Zhao J; Wen X; Xu Y; Li B; Zhang Z; Cai S; Ben X; Qi Y
BMC Med; 2021 Oct; 19(1):243. PubMed ID: 34641873
[TBL] [Abstract][Full Text] [Related]
13. Circulating DNA in Esophageal Cancer-Utility Beyond the Prognostic Application.
Tankel J; Ferri LE
JAMA Surg; 2023 Nov; 158(11):1150-1151. PubMed ID: 37728891
[No Abstract] [Full Text] [Related]
14. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
[TBL] [Abstract][Full Text] [Related]
15. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma.
Hsieh CC; Hsu HS; Chang SC; Chen YJ
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999323
[TBL] [Abstract][Full Text] [Related]
16. From blood to breath: New horizons for esophageal cancer biomarkers.
Yazbeck R; Jaenisch SE; Watson DI
World J Gastroenterol; 2016 Dec; 22(46):10077-10083. PubMed ID: 28028355
[TBL] [Abstract][Full Text] [Related]
17. Circulating cell-free DNA-based methylation pattern in plasma for early diagnosis of esophagus cancer.
Wang R; Yang Y; Lu T; Cui Y; Li B; Liu X
PeerJ; 2024; 12():e16802. PubMed ID: 38313016
[TBL] [Abstract][Full Text] [Related]
18. Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer.
Chen H; Xu C; Fang Z; Mao S
Methods Mol Biol; 2023; 2695():165-179. PubMed ID: 37450118
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy with cell free DNA: new horizons for prostate cancer.
Ponti G; Maccaferri M; Percesepe A; Tomasi A; Ozben T
Crit Rev Clin Lab Sci; 2021 Jan; 58(1):60-76. PubMed ID: 32805148
[TBL] [Abstract][Full Text] [Related]
20. Size distribution of cell-free DNA in oncology.
Udomruk S; Orrapin S; Pruksakorn D; Chaiyawat P
Crit Rev Oncol Hematol; 2021 Oct; 166():103455. PubMed ID: 34464717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]